Your browser doesn't support javascript.
loading
Generation of three induced Pluripotent Stem Cell lines from individuals with Hypomyelination with Atrophy of Basal Ganglia and Cerebellum caused by a c.745G>A (p.D249N) autosomal dominant mutation in TUBB4A.
Almad, Akshata A; Garcia, Luis; Takanohashi, Asako; Gagne, Alyssa; Yang, Wenli; Ann McGuire, Jean; French, Deborah; Vanderver, Adeline.
Afiliação
  • Almad AA; Department of Neurology, The Children's Hospital of Philadelphia, Philadelphia, PA, United States.
  • Garcia L; Department of Neurology, The Children's Hospital of Philadelphia, Philadelphia, PA, United States.
  • Takanohashi A; Department of Neurology, The Children's Hospital of Philadelphia, Philadelphia, PA, United States.
  • Gagne A; Penn Institute for Regenerative Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Yang W; Penn Institute for Regenerative Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Ann McGuire J; Department of Pathology and Lab Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, United States.
  • French D; Department of Pathology and Lab Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, United States.
  • Vanderver A; Department of Neurology, The Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Stem Cell Res ; 69: 103083, 2023 06.
Article em En | MEDLINE | ID: mdl-37003180
Mutations in tubulin alpha 4a (TUBB4A) result in a spectrum of leukodystrophies, including Hypomyelination with atrophy of basal ganglia and cerebellum (H-ABC), resulting from a recurring mutation p.Asp249Asn (TUBB4AD249N). H-ABC presents with dystonia, motor and cognitive impairment and pathological features of hypomyelination and loss of cerebellar and striatal neurons. We have generated three induced pluripotent stem cell (iPSC) lines from fibroblast and peripheral blood mononuclear cells (PBMCs) of individuals with TUBB4AD249N mutation. The iPSCs were assessed to confirm a normal karyotype, pluripotency, and trilineage differentiation potential. The iPSCs will allow for disease modeling, understanding mechanisms and testing of therapeutic targets.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células-Tronco Pluripotentes Induzidas Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células-Tronco Pluripotentes Induzidas Idioma: En Ano de publicação: 2023 Tipo de documento: Article